Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

100
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
100
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

29
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
29
Biostatistics: Overview01:20

Biostatistics: Overview

222
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
222
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

308
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
308
Actuarial Approach01:20

Actuarial Approach

63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitigating bias in the analysis and inferences from using longitudinal EHR data in disease outcomes research.

BMC medical research methodology·2026
Same author

Synthesis and characterization of a novel phosphatidylinositol 5-phosphate (PI(5)P) photoaffinity probe.

RSC chemical biology·2026
Same author

Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin: A Randomized Controlled Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Using routinely collected data for research purposes: challenges and mitigation strategies.

BMJ (Clinical research ed.)·2026
Same author

Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas.

Journal of hematology & oncology·2026
Same author

Demographics and clinical implications of a global bibliographic profile for the hypertrophic cardiomyopathy literature over 66 years (1960-2025).

International journal of cardiology·2026

Related Experiment Video

Updated: Jun 7, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.6K

Bayesian Analytical Methods in Cardiovascular Clinical Trials: Why, When, and How.

Samuel Heuts1, Michal J Kawczynski1, Ahmed Sayed2

  • 1Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands.

The Canadian Journal of Cardiology
|November 9, 2024
PubMed
Summary

Bayesian statistical methods offer a clinically intuitive approach for analyzing cardiovascular trials by incorporating prior evidence. This guide helps physicians understand and perform Bayesian analyses, enhancing treatment effect estimations and uncertainty quantification.

More Related Videos

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
08:05

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

Published on: May 19, 2021

3.6K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.2K

Related Experiment Videos

Last Updated: Jun 7, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.6K
Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
08:05

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

Published on: May 19, 2021

3.6K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.2K

Area of Science:

  • Cardiovascular Medicine
  • Biostatistics
  • Clinical Trial Design

Background:

  • Bayesian statistical inference is increasingly utilized in cardiovascular randomized trials.
  • Understanding Bayesian methods is crucial for practicing cardiovascular physicians due to their guideline-shaping impact.
  • This review addresses the need for a clear guide to Bayesian analysis in cardiovascular research.

Purpose of the Study:

  • To provide a step-by-step guide for interpreting and performing Bayesian reanalyses of cardiovascular clinical trials.
  • To highlight the advantages of Bayesian inference for clinical readers.
  • To demonstrate the clarity and versatility of Bayesian methods through reanalysis of existing trials.

Main Methods:

  • Introduction to frequentist and Bayesian statistical inference concepts.
  • Detailed steps for Bayesian analysis: defining research questions, trial design, prior elicitation, likelihood identification, and posterior distribution computation.
  • Transparent prespecification of multiple priors to prevent post hoc manipulation.

Main Results:

  • Bayesian analysis allows estimation of treatment effects and their uncertainties.
  • The posterior distribution enables calculation of the probability of treatment superiority and exceeding minimal clinically important differences.
  • Reanalysis of three cardiovascular trials demonstrates the practical application and benefits of Bayesian inference.

Conclusions:

  • Bayesian statistical framework provides clinically intuitive insights into treatment effects and uncertainties.
  • This methodology enhances the interpretation of cardiovascular clinical trial data.
  • The guide empowers cardiovascular physicians to confidently apply Bayesian analysis in their practice.